Irreversible Electroporation
Irreversible Electroporation is a medical device with 29 clinical trials. Currently 3 active trials ongoing. Historical success rate of 75.0%.
Success Metrics
Based on 9 completed trials
Phase Distribution
Phase Distribution
3
Early Stage
8
Mid Stage
0
Late Stage
Highest Phase Reached
Phase 2Trial Status & Enrollment
56.3%
9 of 16 finished
43.8%
7 ended early
3
trials recruiting
29
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Irreversible Electroporation & Pembro Immunotherapy in Locally Advanced Pancreatic Cancer
IRE Combined With the Dual-Function Antibody PD-1/CTLA-4 for the Treatment of LAPC Following Failure of First-Line AG Therapy
Immunotherapy and Irreversible Electroporation in the Treatment of Advanced Pancreatic Adenocarcinoma
International Study on Treatment of Liver (HCC) Patients With IRE
International Study on Treatment of Patients With Metastatic Colorectal Liver Lesions Patients With IRE
Clinical Trials (29)
Irreversible Electroporation & Pembro Immunotherapy in Locally Advanced Pancreatic Cancer
IRE Combined With the Dual-Function Antibody PD-1/CTLA-4 for the Treatment of LAPC Following Failure of First-Line AG Therapy
Immunotherapy and Irreversible Electroporation in the Treatment of Advanced Pancreatic Adenocarcinoma
International Study on Treatment of Liver (HCC) Patients With IRE
International Study on Treatment of Patients With Metastatic Colorectal Liver Lesions Patients With IRE
Pivotal Study of the NanoKnife System for the Ablation of Prostate Tissue
Irreversible Electroporation Ablation Combined With Anti-PD(L)1 Therapy for Locally Advanced Pancreatic Cancer
COLDFIRE-III Trial: Efficacy of Irreversible Electroporation and Stereotactic Body Radiotherapy for Perivascular and Peribiliary Colorectal Liver Metastases
Electroporation and Immunotherapy in Metastatic Colorectal Cancer
A Study of the Use of Irreversible Electroporation in Pancreatic Ductal Cancer
Pilot Study on the Evaluation of Irreversible Electroporation Technique in Infiltrating Perihilar Cholangiocarcinoma
Electroporation Potentiated Immunotherapy in Cancer
Phase II/III of Randomized Controlled Clinical Research on IRE Synchronous Chemotherapy for LAPC
Irreversible Electroporation(IRE) For Unresectable Renal Tumors
A Pilot Study of IRE for Resectable Pancreatic Cancer
Irreversible Electroporation of Unresectable Liver Tumors
Simultaneous Gemcitabine and Irreversible Electroporation for Locally Advanced Pancreatic Cancer
Immunological Response After Ablative Therapy in the Liver
An Open-label, Multicenter, Prospective Study of Irreversible Electroporation (Nano Knife) Combined With Radiotherapy and Chemotherapy in Patients With Locally Advanced Pancreatic Cancer
Quality of Life After in Situ IRE in Locally Advanced Pancreatic Cancer
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 29